Tuesday, February 19, 2013

Mark Your Calendar for Memories Gala 2013



Save April 26, 2013 to join us at our 5th Annual Memories Gala at Valley Mansion, 524 Cranbrook Ave. Cockeysville, MD 21031 

The folks at Susie's Cause are so excited to have as our special guest this year Dr. Joel Fuhrman, a board-certified family physician, NY Times best-selling author and nutritional researcher who specializes in preventing and reversing disease through nutritional and other natural methods. We are honored that Dr. Fuhrman will join us so we can thank him for his contributions to cancer prevention over the years.
 
This year's Gala will have dinner, dancing, and a short presentation from Dr. Fuhrman. Of course the Gala will feature plenty of healthy and delicious gourmet Maryland specialties, deluxe open bar and live music featuring Hero, a high energy Baltimore & DC dance band.

Last year's silent auction featured some fabulous items and this year will feature much more to attract your bidding interest!

You may be interested in the following books by Dr. Fuhrman.
These books have much to teach us about how eating healthy foods can reverse disease and help protect us from cancer and other diseases:

·Super Immunity: The Essential Nutrition Guide for Boosting Your Body’s Defenses to Live Longer, Stronger, and Disease Free

· Eat to Live: The Amazing Nutrient-Rich Program for Fast and Sustained Weight Loss

· The End of Diabetes
 
Let’s Celebrate!
We have worked so hard to share knowledge and spread awareness about colon cancer and once a year, during Susie’s Cause Colon Cancer Screening Month, we like to kick up our heels and celebrate with all the wonderful people who join us.


The gala gives people the opportunity to connect with others while enjoying a lively evening and awesome music and dancing. Over the past eight years, the Foundation has grown to become the National Voice for the prevention of colon cancer.

For ticket information, please contact Foundation Director and Event Coordinator Kim Cohan at 410.244.1778 or email kim@coloncancerfoundation.org


If you are unable to attend, please consider making a donation to Susie's Cause. DONATE

Wednesday, February 13, 2013

How Will You Say "I Love You" this Valentine's Day?


Screening, prevention and awareness keep lovers together longer.



 It’s Valentine’s Day!  How are you planning to show your loved ones how much you care?

Have you considered:
   •flowers?
   •candy?
   •cards?
   •dinner?

What about giving them the gift of peace of mind this year by scheduling your colon cancer screening? It might not be as much  fun as a romantic evening out.  But it might  just save your life.  And what a gift that would be!

Break the silence about colon cancer, learn more about screening.    


Did You Know?

Last year alone, over 50,000 people died of colon cancer. It is the second leading cause of cancer-related deaths of men and women. This is due in part to the lack of comfort about discussion of the disease and proper screening efforts. The encouraging truth is that this disease is over 90% curable when detected and treated early.
Does Susie's message speak to you? Donate today in honor of your love.







Tuesday, February 05, 2013

FDA Approves New Use of Avastin for Some Metastatic Colorectal Cancer Patients

If you or a loved one is battling colon cancer, you may be interested in reading about a new option for some Avastin therapy users.

On January 23, 2013, The U.S. Food and Drug Administration (FDA) approved Avastin, (Genentech U.S., Inc.) for use in combination with fluoropyrimidine-irinotecan or fluoropyrimidine-oxaliplatin-based chemotherapy for people with metastatic colorectal cancer (mCRC) whose disease has progressed.

“The majority of people diagnosed with mCRC receive Avastin plus chemotherapy as their initial treatment,” said Hal Barron, M.D., chief medical officer and head of Global Product Development. “These people now have the option to continue with Avastin plus a new chemotherapy after their cancer worsens, which may help them live longer than changing to the new chemotherapy alone,” he added.

The FDA approval is based on positive results from the Phase III ML18147 study, which was presented at the American Society of Clinical Oncology annual meeting and showed that people who continued to receive an Avastin-based regimen after their cancer worsened lived longer than people who switched to chemotherapy alone. Median overall survival was 11.2 months compared to 9.8 months.

Screening Saves Lives

Think about it. One out of 20 U.S. citizens will experience colon cancer in their lifetime. Last year alone, over 50,000 people died of colon cancer. How can that be when this disease is over 90% curable when detected and treated early? Still, colon cancer remains the second leading cause of cancer-related deaths of men and women. People are dying because they are not finding the cancer soon enough. This is due, in part, to the lack awareness about screening and the difficulty that some find in discussing the disease and reporting symptoms. But what can you do? You can help Susie's Cause in their effort to increase awareness, not only about colon cancer, but also about how screening works and how it can save lives.
 
Looking for Information on Treatment Options?

Check our treatment page for a breakdown of information on several colon cancer treatment types.
[Treatment Types]  

Sources:

http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm336763.htm  [FDA]

 http://www.gene.com/media/press-releases/14307/2013-01-23/fda-approves-new-use-of-avastin-plus-che/Genentech   [Genentech: A Member of the Roche Group]

Medical Disclaimer:

The information presented on the Susan Cohan Colon Cancer web site is solely intended to provide you with information that will help educate you on the importance of diet, exercise and regular cancer screening in maintaining a healthy lifestyle. Adopting these habits is an individual choice and one that should only be made after consultation with your health care professional. No information provided on this Web site or otherwise is intended to replace or in any way modify the advice of your health care professional.